Your browser doesn't support javascript.
loading
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.
Fujii, Hironori; Araki, Ayumu; Iihara, Hirotoshi; Kaito, Daizo; Hirose, Chiemi; Kinomura, Motohiko; Yamazaki, Mizuki; Endo, Junki; Inui, Toshiya; Yanase, Komei; Sasaki, Yuka; Gomyo, Takenobu; Sakai, Chizuru; Kawae, Daisuke; Kitamura, Yu; Fukui, Masachika; Kobayashi, Ryo; Ohno, Yasushi; Suzuki, Akio.
Afiliación
  • Fujii H; Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Araki A; Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Iihara H; Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Kaito D; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Hirose C; Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Kinomura M; Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Yamazaki M; Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Endo J; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Inui T; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Yanase K; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Sasaki Y; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Gomyo T; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Sakai C; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Kawae D; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Kitamura Y; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Fukui M; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Kobayashi R; Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Ohno Y; Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
  • Suzuki A; Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Mol Clin Oncol ; 16(4): 91, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35251642
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido